P

Inventor

DING MIN

CN57 patents
⚠️ This page may combine multiple inventors who share the name “DING MIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

24 patents
US7153848B2Dec 26, 2006

Inhibitors of HCV replication

BRISTOL MYERS SQUIBB CO90 citations98
US7348425B2Mar 25, 2008

Inhibitors of HCV replication

BRISTOL MYERS SQUIBB CO59 citations94
US7485633B2Feb 3, 2009

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO20 citations92
US7456166B2Nov 25, 2008

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO24 citations92
US7452876B2Nov 18, 2008

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO21 citations92
US9850225B2Dec 26, 2017

Compounds useful as immunomodulators

BRISTOL MYERS SQUIBB CO13 citations84
US7547690B2Jun 16, 2009

Compounds for the treatment of Hepatitis C

BRISTOL MYERS SQUIBB CO8 citations84
US7541353B2Jun 2, 2009

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO11 citations84
US7541351B2Jun 2, 2009

Compounds for the treatment of hepatitis C

BRISTOL MYERS SQUIBB CO11 citations84
US7538102B2May 26, 2009

Compounds for the treatment of Hepatitis C

BRISTOL MYERS SQUIBB CO16 citations84
US7521443B2Apr 21, 2009

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO13 citations84
US7521442B2Apr 21, 2009

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO18 citations84
US7521441B2Apr 21, 2009

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

BRISTOL MYERS SQUIBB CO18 citations84
US6034113AMar 7, 2000

Derivatives of 1,3,4-oxadiazolone

BRISTOL MYERS SQUIBB CO11 citations74
US11866430B2Jan 9, 2024

Naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO3 citations73
US10669272B2Jun 2, 2020

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO4 citations70
US5948802ASep 7, 1999

Benzoate derivatives of diaryl 1,3,4-oxadiazolone

BRISTOL MYERS SQUIBB CO2 citations63
US8383094B2Feb 26, 2013

Hepatitis C virus inhibitors

BRISTOL MYERS SQUIBB CO3 citations62
US11713316B2Aug 1, 2023

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations59
US7169803B2Jan 30, 2007

N-substituted prodrugs of fluorooxindoles

BRISTOL MYERS SQUIBB CO1 citations52
US9738642B2Aug 22, 2017

Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders

BRISTOL MYERS SQUIBB CO1 citations51
US11964973B2Apr 23, 2024

Substituted bicyclic compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations50
US8354548B2Jan 15, 2013

Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase

BRISTOL MYERS SQUIBB CO0 citations50

DING MIN

5 patents

NEC LAB AMERICA INC

3 patents

FREESCALE SEMICONDUCTOR INC

3 patents

CHIESI FARM SPA

3 patents

THE MEDICINES CO

2 patents

MEANWELL NICHOLAS A

1 patent

MEDICINES CO

1 patent

INTELLIGENT AUTOMATION INC

1 patent

CORNING RES & DEV CORP

1 patent

MARTIN SCOTT W

1 patent

PHARCHOICE THERAPEUTICS INC

1 patent

GLOBE JIANGSU CO LTD

1 patent

CHOPIN SHEILA F

1 patent

3M INNOVATIVE PROPERTIES COMPANY

1 patent

MELINTA THERAPEUTICS INC

1 patent

Showing the top 50 of 57 patents by PatentIndex Score.